Biotechnology
Biotechnology Market Research, Intelligence and Forecasts
In this section you will find information products, including market research, covering the global biotechnology industry, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
|
Biosimilars: A Growing Market |
March 2010 | £1495 |
|
Gene Therapy Technologies, Markets and Companies |
March 2010 | £2970 |
|
Biomarkers Technologies, Markets and Companies |
March 2010 | £2970 |
|
RNAi Technologies, Markets and Companies |
March 2010 | £2310 |
|
Proteomics Technologies, Markets and Companies |
March 2010 | £2970 |
|
DNA Sequencing Technologies, Markets and Companies |
March 2010 | £1190 |
|
Cytogenetics Technologies, Markets and Companies |
March 2010 | £1455 |
|
Nanobiotechnology Applications, Markets and Companies |
March 2010 | £2970 |
|
Stem Cell Research Market Trends, Investment Trends and Pipeline Analysis |
February 2010 | £2310 |
|
Fermenters |
February 2010 | £2280 |
|
Prebiotics |
February 2010 | £2280 |
|
Ribonucleic Acid (RNA) Therapeutics Strong Potential to Address Unmet Needs in Pharma |
February 2010 | £2310 |
|
Nanobiotechnology |
February 2010 | £2940 |
|
Top 10 Biotechnology Companies SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline |
February 2010 | £2310 |
|
Small and Medium Biopharmaceutical Enterprises in North America and Europe Biotechnology Clusters, Funding Characteristics and Regulatory Landscape |
February 2010 | £2310 |
|
Epigenetics |
February 2010 | £2970 |
|
Biomarkers, Tests and Trends for Drug R&D |
February 2010 | £1450 |
|
Chinese Markets for Monoclonal Antibody |
January 2010 | £2640 |
|
The Future of Monoclonal Antibodies Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis |
December 2009 | £2310 |
|
The Future of Biosimilars Market Forecasts to 2015 |
December 2009 | £2310 |
|
Marine Biotechnology Worldwide Market Trends |
November 2009 | £1980 |
|
Biotechnology Instrumentation International Market Trends |
November 2009 | £1980 |
|
Antibiotics Global Trends |
November 2009 | £1980 |
|
Biotechnology Reagents A Global Market Perspective |
November 2009 | £1980 |
|
Regenerative Medicine Global Market Trends |
November 2009 | £1980 |
|
Antibiotic Resistance and Antibiotic Technologies: Global Markets |
November 2009 | £3205 |
|
Biochips A Global Update of Market Trends & Opportunities |
November 2009 | £1980 |
|
Automated and Rapid Microbiological Tests A Worldwide Market Review |
November 2009 | £1980 |
|
Agricultural Biotechnology Global Market Trends |
November 2009 | £1980 |
|
Chiral Technology International Technology & Market Trends |
November 2009 | £1980 |
|
Agricultural and Environmental Diagnostics A World Market Review |
November 2009 | £1980 |
|
Biometrics Trends & Opportunities Worldwide |
November 2009 | £1980 |
|
Gene Amplification Technologies Trends & Opportunities Worldwide |
November 2009 | £1980 |
|
Proteomics International Market Trends |
November 2009 | £1980 |
|
Asia Pacific Market for Bone Graft Substitutes and Other Biomaterials 2009 (3 Countries) |
November 2009 | £5610 |
|
Probiotics A Global Update of Market Trends & Opportunities |
November 2009 | £1980 |
|
Gene Therapy Worldwide Market Challenges & Opportunities |
November 2009 | £1980 |
|
Cord Blood Stem Cells A Global Market Overview |
October 2009 | £2855 |
|
Biotechnology Global Industry Guide |
October 2009 | £985 |
|
Global Biotechnology IBISWorld Industry Report |
September 2009 | £495 |
|
Contract Biomanufacturing Organization directory Strategic sourcing tool |
Ongoing | £540 |
|
Biotechnological Innovations In The Pharmaceutical Industry in Poland 2009 Development forecasts for biotechnology sector for 2009-2011 |
August 2009 | £1790 |
|
World Market for Biosimilars and the Potential for US Follow-on Biologics, The |
August 2009 | £2445 |
|
Global Protein Therapeutics Market Analysis |
August 2009 | £1190 |
|
Becton-Dickinson Medical Device Company Intelligence Report |
July 2009 | £295 |
|
Stem Cell Markets |
June 2009 | £2245 |
|
Biosimilars Series: Forecast Analysis |
June 2009 | £7530 |
|
Biosimilars Problems, Prospects and Projections |
April 2009 | £225 |
|
6th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production |
April 2009 | £1115 |
|
Companion Biomarkers in Drug Development |
April 2009 | £2245 |
|
Biosimilars and Follow-On Biologics Report The Global Outlook 2009-2024 |
April 2009 | £1499 |
|
A Quick Guide to Biotechnology and Healthcare in the Middle East |
April 2009 | £190 |
|
Biotechnology in Australia IBISWorld Industry Report |
April 2009 | £390 |
|
Success Rates in Biotech Going The Wrong Way |
March 2009 | £885 |
|
Bioinformatics Markets Strategies, Business Models and Trends for the Future |
March 2009 | £2245 |
|
Biotechnology in the US IBISWorld Industry Report |
March 2009 | £430 |
|
The Future of Biobanks Regulation, ethics, investment and the humanization of drug discovery |
March 2009 | £2025 |
|
Opportunities Assessment for Hepatitis B Therapeutics in Thailand |
March 2009 | £3965 |
|
Strategic Analysis of U.S. MicroRNA Services Markets |
March 2009 | £3965 |
|
Bioinformatics Market Potential |
January 2009 | £395 |
|
Understanding the Global Biotech Industry The New 'Engine' of the Global Economy |
January 2009 | £395 |
|
Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications 2nd Edition |
December 2008 | £2640 |
|
RNA Interference Markets |
December 2008 | £2245 |
|
Biologic Imaging Reagents Technologies and Global Markets |
December 2008 | £3205 |
|
Top 10 Biotech Companies Market Outlook, 2008-2023 |
December 2008 | £1499 |
|
Quality for Biologics Critical quality attributes, process and change control, product variation, characterisation, and regulatory concerns |
December 2008 | £1495 |
|
Biopharmaceutical Expression Systems and Genetic Engineering Technologies Current and Future Manufacturing Platforms |
November 2008 | £425 |
|
MarketWatch: Biotechnology |
November 2008 | £69 |
|
Stem Cells Come of Age |
November 2008 | £2475 |
|
Global Biotechnology Markets Trends |
November 2008 | £460 |
|
Future of RNAi Therapeutics, The Drug Pipelines and Prospects |
September 2008 | £1995 |
|
Microarray Markets |
September 2008 | £1320 |
|
Biosimilars: a viable market? |
September 2008 | £1295 |
|
U.S. Chemical and Biological Detection Markets |
September 2008 | £2570 |
|
U.S. Stem Cell Market - Current Development |
September 2008 | £2570 |
|
Directory of Top 60 Biopharmaceutical Manufacturers in INDIA |
September 2008 | £920 |
|
Biotechnology in China |
September 2008 | £120 |
|
Biotechnology in Belgium |
September 2008 | £120 |
|
Biotechnology in Asia-Pacific |
September 2008 | £120 |
|
Biotechnology in Canada |
September 2008 | £120 |
|
Biotechnology in the United States |
September 2008 | £120 |
|
Biotechnology in Europe |
September 2008 | £120 |
|
Biotechnology in the Netherlands |
September 2008 | £120 |
|
Biotechnology in the United Kingdom |
September 2008 | £120 |
|
Global Biotechnology |
September 2008 | £120 |
|
Biotechnology in Japan |
September 2008 | £120 |
|
Biotechnology in Spain |
September 2008 | £120 |
|
Biotechnology in France |
September 2008 | £120 |
|
Biotechnology in Italy |
September 2008 | £120 |
|
Biotechnology in Germany |
September 2008 | £120 |
|
Medical Nanotechnology Markets |
September 2008 | £2245 |
|
China Pharmaceutical & Biotechnology Monthly (Single user, one year subscription) |
September 2008 | £1320 |
|
Synthes Medical Device Company Intelligence Report |
August 2008 | £295 |
|
Practical Systems Biology Demonstrating Value Today in Pharma R&D |
August 2008 | £990 |
|
Global Biotech Market Analysis and Forecasts, 2008-2023 |
August 2008 | £1499 |
|
Baylor Health Care System - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Inova Health System - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
New York City Health and Hospitals Corporation - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Sutter Health - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
MedCath Corporation - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Mayo Foundation for Medical Education and Research - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
NewYork- Presbyterian Hospital - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Stille Ab - Healthcare - Medical Equipment SWOT Report |
August 2008 | £83 |
|
Sisters of Mercy Health System - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Spectrum Health System - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Ramsay Health Care Limited - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Providence Health System - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
LifePoint Hospitals, Inc. - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
XCounter Ab - Healthcare - Medical Equipment SWOT Report |
August 2008 | £83 |
|
Cml Healthcare Income Fund - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Clarian Health Partners, Inc. - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Christus Health - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Catholic Healthcare Partners - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Group Health Cooperative - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Hip Health Plan of New York - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Jefferson Health System, Inc. - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Xceed Biotechnology Limited - Healthcare - Medical Equipment SWOT Report |
August 2008 | £83 |
|
Intermountain Healthcare, Inc. - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Catholic Health Services of Long Island - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Southern Cross Healthcare Group Plc - Healthcare - Managed Care and Hospitals SWOT Report |
August 2008 | £83 |
|
Spectrum Surgical Instruments Corporation Medical Equipment Company Share Analysis |
July 2008 | £660 |
|
Karl Storz Gmbh & Co. Kg Medical Equipment Company Share Analysis |
July 2008 | £660 |
|
Medikro Oy. Medical Equipment Company Share Analysis |
July 2008 | £660 |
|
Shofu Inc. Medical Equipment Company Share Analysis |
July 2008 | £660 |
|
Ontex International N.V. Medical Equipment Company Share Analysis |
July 2008 | £660 |
|
DNA Sequencing and PCR Markets |
July 2008 | £2245 |
|
Biopharmaceuticals in South East Asia |
July 2008 | £795 |
|
Microscopy Markets |
July 2008 | £2245 |
|
Daiichi Sankyo: Pipeline, Products, Performance, Potential |
June 2008 | £595 |
|
Barr Pharmaceuticals Generics Company Intelligence Report |
June 2008 | £195 |
|
Mylan Laboratories Generics Company Intelligence Report |
June 2008 | £195 |
|
Teva Pharmaceutical Industries Generics Company Intelligence Report |
June 2008 | £195 |
|
Eisai Pipeline - Products - Performance - Potential |
June 2008 | £595 |
|
Dr Reddy's Laboratories Generics Company Intelligence Report |
June 2008 | £195 |
|
Dr Reddy's Laboratories Generics Company Intelligence Report |
June 2008 | £195 |
|
SNP Genotyping and Analysis Markets |
June 2008 | £2640 |
|
Booming Biotech Market in India |
June 2008 | £465 |
|
Monoclonal Antibodies Report |
June 2008 | £2510 |
|
Larka CMO Companies Listing Strategic sourcing tool |
Ongoing | £540 |
|
Shionogi: Pipeline - Products - Performance - Potential |
April 2008 | £595 |
|
Boehringer Ingelheim: Pipeline, Products, Performance, Potential |
April 2008 | £595 |
|
Shionogi Pipeline, Products, Performance, Potential |
April 2008 | £595 |
|
Biomarker Technology Platforms for Cancer Diagnoses and Therapies |
April 2008 | £2245 |
|
Biogenerics, The World Market Biosimilars and Follow-On Biologics at a Crossroads |
April 2008 | £2310 |
|
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production A Study of Biotherapeutic Developers and Contract Manufacturing Organizations, 2007 |
April 2008 | £1050 |
|
Fastest Growing Biotechnology Companies, The Growth Strategies, Comparative Analyses and Company Profiles |
March 2008 | £1995 |
|
Threshold Pharmaceuticals Inc Premium Company Profile |
March 2008 | £175 |
|
Somaxon Pharmaceuticals Inc Premium Company Profile |
March 2008 | £175 |
|
MicroRNAs Commercial Products on the Horizon |
March 2008 | £745 |
|
Indian Biotechnology Industry Report |
March 2008 | £400 |
|
Label Free Binding Analysis Trends 2008 |
March 2008 | £1540 |
|
Smiths Medical Strategic Analysis Profile |
February 2008 | £520 |
|
Siemens Medical Solutions Strategic Analysis Profile |
February 2008 | £520 |
|
SonoSite, Inc. Strategic Analysis Profile |
February 2008 | £520 |
|
Sorin S.p.A. Strategic Analysis Profile |
February 2008 | £520 |
|
Sectra AB Strategic Analysis Profile |
February 2008 | £36 |
|
St. Jude Medical Inc. Strategic Analysis Profile |
February 2008 | £520 |
|
STERIS Corporation Strategic Analysis Profile |
February 2008 | £36 |
|
Luxottica Group S.p.A. Strategic Analysis Profile |
February 2008 | £520 |
|
Kinetic Concepts, Inc. Strategic Analysis Profile |
February 2008 | £36 |
|
Nobel Biocare Holding AG Strategic Analysis Profile |
February 2008 | £50 |
|
Orthofix International N.V. Strategic Analysis Profile |
February 2008 | £520 |
|
Philips Medical Systems Strategic Analysis Profile |
February 2008 | £520 |
|
Straumann Holding AG Strategic Analysis Profile |
February 2008 | £520 |
|
Synthes GmbH Strategic Analysis Profile |
February 2008 | £520 |
|
ZOLL Medical Corporation Strategic Analysis Profile |
February 2008 | £36 |
|
Wright Medical Group, Inc. Strategic Analysis Profile |
February 2008 | £36 |
|
bioMerieux S.A. Strategic Analysis Profile |
February 2008 | £520 |
|
Johnson & Johnson Strategic Analysis Profile |
February 2008 | £520 |
|
KYOWA HAKKO KOGYO Co., Ltd. Strategic Analysis Profile |
February 2008 | £520 |
|
Wavelight AG check Strategic Analysis Profile |
February 2008 | £520 |
|
Thoratic Corporation Strategic Analysis Profile |
February 2008 | £520 |
|
Teleflex Incorporated Strategic Analysis Profile |
February 2008 | £36 |
|
Terumo Corporation Strategic Analysis Profile |
February 2008 | £50 |
|
The Cooper Companies, Inc. Strategic Analysis Profile |
February 2008 | £520 |
|
Thermo Fisher Scientific Inc. Strategic Analysis Profile |
February 2008 | £36 |
|
Symmetry Medical Inc. Strategic Analysis Profile |
February 2008 | £36 |
|
Invacare Corporation Strategic Analysis Profile |
February 2008 | £520 |
|
B. Braun Melsungen AG Strategic Analysis Profile |
February 2008 | £520 |
|
Bayer Healthcare Strategic Analysis Profile |
February 2008 | £520 |
|
Biosite Incorporated Strategic Analysis Profile |
February 2008 | £520 |
|
Carl Zeiss Meditec AG Strategic Analysis Profile |
February 2008 | £520 |
|
Arrow International, Inc. Strategic Analysis Profile |
February 2008 | £520 |
|
Ansell Limited Strategic Analysis Profile |
February 2008 | £50 |
|
ABIOMED, Inc. Strategic Analysis Profile |
February 2008 | £36 |
|
Accuray Incorporated Strategic Analysis Profile |
February 2008 | £520 |
|
Air Liquide Strategic Analysis Profile |
February 2008 | £36 |
|
Alliance Imaging, Inc. Strategic Analysis Profile |
February 2008 | £36 |
|
Coloplast AS Strategic Analysis Profile |
February 2008 | £520 |
|
C. R. Bard, Inc. Strategic Analysis Profile |
February 2008 | £520 |
|
DJO Incorporated Strategic Analysis Profile |
February 2008 | £520 |
|
Fresenius SE Strategic Analysis Profile |
February 2008 | £520 |
|
Haemonetics Corporation Strategic Analysis Profile |
February 2008 | £36 |
|
Hanger Orthopedic Group, Inc. Strategic Analysis Profile |
February 2008 | £36 |
|
IDEXX Laboratories, Inc. Strategic Analysis Profile |
February 2008 | £520 |
|
F. Hoffmann-La Roche Ltd. Strategic Analysis Profile |
February 2008 | £520 |
|
Gyrus Group PLC Strategic Analysis Profile |
February 2008 | £520 |
|
DaVita Inc. Strategic Analysis Profile |
February 2008 | £520 |
|
Elekta AB Strategic Analysis Profile |
February 2008 | £36 |
|
Datascope Corp. Strategic Analysis Profile |
February 2008 | £36 |
|
Edwards Lifesciences Corporation Strategic Analysis Profile |
February 2008 | £36 |
|
Advances in Biopharmaceutical Technology in India |
February 2008 | £1995 |
|
Environmental Markets for Biotechnology |
January 2008 | £3205 |
|
China Molecular Diagnostics & Database Package |
January 2008 | £3300 |
|
Antibiotics and Drug Resistance 2008 Drug Innovation and the Strategy to Combat - Antibiotic Resistance Mechanisms |
January 2008 | £1499 |
|
China Biotech 2008 & Database Package |
January 2008 | £330 |
|
Cell Based Label-Free Detection Trends 2007 |
January 2008 | £1540 |
|
Indian Biopharmaceuticals |
January 2008 | £600 |
|
Innovations in Bioinformatics Emerging Tools for Drug Discovery and Development |
January 2008 | £1995 |
|
Launching Combination Products Brand Extension and Franchise Development Strategies |
January 2008 | £1995 |
|
Indian Biotechnology |
January 2008 | £600 |
|
China Vaccine & Database Package |
December 2007 | £3300 |
|
TR-FRET Based Assay Trends 2008 |
December 2007 | £1540 |
|
Immunogenicity to Biologics Implications Of Reactions Against Biotech Drugs |
November 2007 | £1450 |
|
Premium Company Profile: Invitrogen Corporation |
November 2007 | £175 |
|
Premium Company Profile: BioMarin Pharmaceutical Inc. |
November 2007 | £175 |
|
Biomarkers The Expanding Global Market |
November 2007 | £3205 |
|
RNAi Therapeutics 2008 |
November 2007 | £2350 |
|
Biosimilars Series Strategic Issues - Potential Remains Uncertain |
October 2007 | £1320 |
|
Pharmaceutical Biotechnology: Fundamentals and Applications Third Edition |
October 2007 | £115 |
|
Building Pharmaceutical-Biotechnology Partnerships and Alliances Market Preparation & Strategic Support |
October 2007 | £4620 |
|
Monoclonal Antibodies Report Part II Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff |
September 2007 | £2510 |
|
U.S. Bioethanol & Cellulosic Ethanol Market & Future Direction |
September 2007 | £985 |
|
Biomanufacturing Strategies Market Drivers, Build-Vs-Buy Decisions And Opportunities In Contract Relationship Management |
September 2007 | £1495 |
|
Microplate Mixing Trends 2007 |
September 2007 | £1540 |
|
Stem Cells 2007-2008 |
September 2007 | £2350 |
|
China Biotherapeutics Database 2006 |
September 2007 | £1005 |
|
World Enzymes Study # 2229 |
September 2007 | £3565 |
|
Biopharmaceutical Products in the US and European Markets 6th Edition |
September 2007 | £985 |
|
Personalized Medicine |
August 2007 | £1320 |
|
Pigments: Inorganic, Organic & Specialty |
August 2007 | £1475 |
|
Global Biotechnology Industry 2006 - Power Point Presentation (Editable) |
July 2007 | £400 |
|
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge Of Turning Technology Into Therapy |
July 2007 | £1999 |
|
Global Biotechnology -Yearly Update 2006 |
July 2007 | £600 |
|
Company Study of Shanghai Kehua Bio-engineering Co. Ltd., 2007 |
July 2007 | £195 |
|
European Biotech Industry Guide 2007 5th Edition |
July 2007 | £535 |
|
Nanotoxicology: Characterization, Dosing and Health Effects |
July 2007 | £432 |
|
Monoclonal Antibodies Report Part I |
June 2007 | £2510 |
|
Monoclonal Antibodies Report Market Model |
June 2007 | £2510 |
|
Asia Pacific Biotechnology Market 2007-2010 |
June 2007 | £525 |
|
Asia Pacific Biotechnology Market 2007-2010 |
June 2007 | £1055 |
|
Asia Pacific Biotechnology Market 2007-2010 |
June 2007 | £525 |
|
DNA Sequencing Equipment and Services Markets |
June 2007 | £2640 |
|
Ion Channel Trends 2007 |
June 2007 | £1540 |
|
BIOTECH 2007 Life Sciences A Global Transformation |
May 2007 | £295 |
|
Cardiovascular Multidetector CT Angiography |
May 2007 | £99 |
|
Multi-Mode Microplate Reader Trends 2007 |
May 2007 | £1540 |
|
Minimally Invasive Spine Surgery |
May 2007 | £145 |
|
Canadian Biotech News Industry Report |
April 2007 | £925 |
|
China Antibodies & Database Package |
April 2007 | £1320 |
|
High-Content Analysis 2007 |
April 2007 | £1540 |
|
US Biotech Market Analysis |
March 2007 | £325 |
|
The Dynamic Media, Sera and Reagent Market in Biotechnology |
March 2007 | £3205 |
|
Fluorescence Lifetime Trends 2007 |
March 2007 | £1540 |
|
Biocompatible Materials for the Human Body |
March 2007 | £3205 |
|
China Biopharmaceutical Industry Report, 2006-2007 |
March 2007 | £195 |
|
Siemens Medical Solutions Medical Device Company Intelligence Report |
February 2007 | £395 |
|
Biotech Drug Delivery Systems Key Company Intelligence & Market Outlook to 2012 |
February 2007 | £1299 |
|
Separation Systems for Commercial Biotechnology |
February 2007 | £2885 |
|
Bio/Chemical Sensors The Bourne Report |
February 2007 | £460 |
|
RNAi/MicroRNA 2007 |
February 2007 | £2350 |
|
Biomarkers: A Market Briefing A Market Briefing |
January 2007 | £1320 |
|
Stem Cells - The hype and the hope Business opportunities and forecasts |
January 2007 | £4999 |
|
Analysis Report on Major Enterprises in the Chinese Bearing Industry |
January 2007 | £200 |
|
Genetically Modified Crops Industry Report |
January 2007 | £400 |
|
Indian Biopharmaceuticals Industry Report |
January 2007 | £400 |
|
A Guide to Biosimilars, Biogenerics and Follow-on Biologics |
January 2007 | £1095 |
|
Scrip's Pharmaceutical Company League Tables 2007 |
January 2007 | £1870 |
|
Clinica's Guide to Early-stage Medtech Companies |
January 2007 | £500 |
|
Cell Culture The World Market for Media, Sera, and Reagents |
January 2007 | £2575 |
|
Market for Bioengineered Protein Drugs; The |
January 2007 | £2885 |
|
The China Pharmaceutical Market: A Strategic Opportunity Analysis |
January 2007 | £840 |
|
Microplate Instrument Trends 2007 |
January 2007 | £1540 |
|
Biosimilars: Benchmarking the key players With increasing regulatory clarity and high revenue potential, interest in biosimilars increases |
December 2006 | £2640 |
|
Applied Biosystems Group |
December 2006 | £200 |
|
Biosimilars: Regulatory Issues Europe continues to make strides while the US lags behind |
December 2006 | £1325 |
|
Biotechnology: Global Industry Guide |
December 2006 | £530 |
|
Biopartnering Strategies Maximizing returns from biotechnology deal-making |
December 2006 | £1495 |
|
Global Market for Antimicrobials and Antifungals; The Challenging Resistance to 2016 |
December 2006 | £1600 |
|
Next Generation Battery U.S. Biofuel Cells R&D and Future Directions |
October 2006 | £790 |
|
Biocompatible Materials US industry forecasts to 2010 & 2015 |
September 2006 | £2905 |
|
Advances in Biopharmaceutical Technology in China |
September 2006 | £3410 |
|
China Industrial Biotechnology |
August 2006 | £2640 |
|
Chinese Markets for Biotechnology |
August 2006 | £2640 |
|
Commercial Insight: Antidyslipidemics Branded statins beware, generics are amongst you |
July 2006 | £5575 |
|
Protein and Antibody Microarrays Markets Sector Snapshot |
July 2006 | £330 |
|
Global Biotechnology Industry 2006 |
June 2006 | £550 |
|
Future of BioSciences; The Four Scenarios for 2020 and Their Implications for Human Healthcare |
June 2006 | £990 |
|
Biotech 2010 |
June 2006 | £2885 |
|
In Silico ADME/Tox Products Market 2006 |
June 2006 | £1540 |
|
Automated Low Volume Dispensing Trends 2006 |
June 2006 | £1540 |
|
Biotech in Autoimmune and Inflammatory Disease 2006 2nd Edition |
May 2006 | £1980 |
|
Medical and Biological Sensors and Sensor Systems Markets, Applications, and Competitors Worldwide, 2nd Edition |
May 2006 | £2310 |
|
China Bio-services & Database Package |
May 2006 | £1320 |
|
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets 2006-2011 Analysis & Forecasts |
May 2006 | £725 |
|
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities 2006-2011 Analysis & Forecasts |
May 2006 | £1185 |
|
India: Pharmaceutical and biotechnology opportunities |
April 2006 | £840 |
|
Labeling and Linkage Agents for Immunoassays and Gene Probes |
April 2006 | £2885 |
|
Label Free Detection Trends 2006 |
April 2006 | £1540 |
|
Scrip Yearbook 2007 23rd Edition (2 Volumes) |
January 2006 | £895 |
|
Outlook 2007 |
January 2006 | £895 |
|
Clinica's Indian Market Briefing |
January 2006 | £500 |
|
Clinica's Medical Device and Diagnostic Company League Tables 2006 |
January 2006 | £1095 |
|
Indian Biodiesel Industry Report |
January 2006 | £400 |
|
HCS Imaging Trends |
November 2005 | £1540 |
|
DNA Sequencing: Industry Background Report List of Companies |
October 2005 | £345 |
|
High Content, Cell-Based Analysis Industry Background Report |
October 2005 | £345 |
|
Micro-Arrays: Industry Background Report List of Companies |
October 2005 | £345 |
|
Bioinformatics: Industry Background Report List of Companies |
October 2005 | £345 |
|
Gene Therapy: Industry Background Report List of Companies |
October 2005 | £345 |
|
Stem Cells: Industry Background Report List of Companies |
October 2005 | £295 |
|
Biomarkers: Industry Background Report List of Companies |
October 2005 | £295 |
|
Protein expression: Industry Background Report List of Companies |
October 2005 | £295 |
|
SNPs: Industry Background Report List of Companies |
October 2005 | £295 |
|
Monoclonal Antibodies: Industry Background Report List of Companies |
October 2005 | £400 |
|
Proteomics: Industry Background Report List of Companies |
October 2005 | £400 |
|
Biomaterials: Industry Background Report |
October 2005 | £235 |
|
Protein Microarrays: Technology Adoption & Utilization Technology Adoption & Utilization |
September 2005 | £2970 |
|
Modern Biopharmaceuticals Design, Development and Optimization, 4 Volumes |
September 2005 | £440 |
|
Dynamic Antibody Industry |
August 2005 | £2885 |
|
Bioinformatics Technical Status and Market Prospects |
August 2005 | £2885 |
|
Market for DNA Microarrays; The Core Lab & End-User Perspectives |
August 2005 | £2380 |
|
Biotech Business: June 2005 |
June 2005 | £17 |
|
Biotech Equipment Update: June 2005 |
June 2005 | £17 |
|
Worldwide Biotech June 2005 |
June 2005 | £17 |
|
Handbook of Genome Research Genomics, Proteomics, Metabolomics, Bioinformatics, Ethical and Legal Issues, Two Volumes |
June 2005 | £175 |
|
Biotech Financial Reports: June 2005 |
June 2005 | £17 |
|
Cell Culture: The World Market for Media, Sera and Reagents 2nd Edition |
May 2005 | £2640 |
|
Biotech Business: May 2005 |
May 2005 | £17 |
|
Biotech Equipment Update: May 2005 |
May 2005 | £17 |
|
Worldwide Biotech: May 2005 |
May 2005 | £17 |
|
Biotech Financial Reports: May 2005 |
May 2005 | £17 |
|
Biotech Equipment Update: March 2005 |
March 2005 | £17 |
|
Biotech Business: March 2005 |
March 2005 | £17 |
|
Worldwide Biotech: March 2005 |
March 2005 | £17 |
|
Biotech Financial Reports: March 2005 |
March 2005 | £17 |
|
Biotech Equipment Update: February 2005 |
February 2005 | £17 |
|
Biotech Financial Reports: February 2005 |
February 2005 | £17 |
|
Worldwide Biotech: February 2005 |
February 2005 | £17 |
|
Biotech Business: February 2005 |
January 2005 | £17 |
|
Bioinformatics A Practical Guide to the Analysis of Genes and Proteins, 3rd Edition |
November 2004 | £50.95 |
|
Biostatistics: A Methodology For the Health Sciences 2nd Edition |
August 2004 | £73.5 |
|
Race to Commercialize Biotechnology, The Molecules, Market and the State in Japan and the US |
March 2004 | £80 |
|
Pharmaceutical Biotechnology Drug Discovery and Clinical Applications |
February 2004 | £115 |
|
Nanotubes Report 2004, The |
January 2004 | £1730 |
|
Nanoparticles |
October 2003 | £375 |
|
Biotechnology and Biopharmaceuticals Transforming Proteins and Genes into Drugs |
July 2003 | £55.95 |
|
Biopharmaceuticals: Biochemistry and Biotechnology Second Edition |
July 2003 | £47.5 |
|
Nanotechnology Opportunity Report, The |
June 2003 | £1330 |
|
Medical and Pharmaceutical Market Opportunities |
June 2003 | £300 |
|
Technimanagement: The Human Side of the Organization |
December 1999 | £89 |
